OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $236,000 | -26.2% | 59,473 | -26.0% | 0.00% | – |
| Q4 2018 | $320,000 | -60.9% | 80,403 | -32.4% | 0.00% | – |
| Q3 2018 | $818,000 | +95.7% | 118,946 | +92.0% | 0.00% | – |
| Q2 2018 | $418,000 | -9.7% | 61,943 | -12.9% | 0.00% | – |
| Q1 2018 | $463,000 | +98.7% | 71,087 | +35.8% | 0.00% | – |
| Q4 2017 | $233,000 | -32.3% | 52,351 | -6.0% | 0.00% | – |
| Q3 2017 | $344,000 | -66.6% | 55,719 | -49.8% | 0.00% | -100.0% |
| Q2 2017 | $1,029,000 | +0.6% | 111,019 | +0.7% | 0.00% | 0.0% |
| Q1 2017 | $1,023,000 | +61.4% | 110,234 | +45.5% | 0.00% | – |
| Q4 2016 | $634,000 | +19.8% | 75,785 | -1.5% | 0.00% | – |
| Q3 2016 | $529,000 | +38.8% | 76,935 | 0.0% | 0.00% | – |
| Q2 2016 | $381,000 | -18.6% | 76,935 | +58.7% | 0.00% | – |
| Q1 2016 | $468,000 | +3.1% | 48,468 | 0.0% | 0.00% | – |
| Q4 2015 | $454,000 | -44.3% | 48,468 | -16.4% | 0.00% | -100.0% |
| Q3 2015 | $815,000 | -25.6% | 57,972 | +11.3% | 0.00% | 0.0% |
| Q2 2015 | $1,096,000 | +17.7% | 52,093 | +134.8% | 0.00% | 0.0% |
| Q1 2015 | $931,000 | +229.0% | 22,183 | +84.4% | 0.00% | – |
| Q4 2014 | $283,000 | +79.1% | 12,029 | +14.1% | 0.00% | – |
| Q3 2014 | $158,000 | – | 10,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |